|
| |
| | | 00592 | | 12.12.1996 | | GlaxoSmithKline AG | | | | | | | | | | | | | 08.08. | | | | 08.08. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Twinrix 720/20 | Injektionssuspension | Injection suspension (Hepatitis-A-Virus Inactivatus (Hm175) 720 U/ml, Hepatitidis b viri Antigenum Adnr 20 µg/ml) | J07BC20 | | | 02 | Twinrix 20 | | () | J07BC20 | |
|
|
|
